Patient subjects
Participants were female patients between 18 and 70 years old with at
least one tumor lesion with a diameter of more than 1.5 cm, and could be
treated with reasonable tumor reduction surgery in accordance with NCCN
clinical guidelines. Patients who received radiotherapy within 28 days
before surgery were excluded. Tumor samples in situ were obtained by
hysterectomy, and superficial lymph node metastases were obtained by
minimally invasive surgery. This study was approved by the Medical
Ethics Committee of Sun Yat-sen Memorial Hospital of Sun Yat-sen
University, with the Approval number SYSEC-KY-KS-2019-147.